English
简体中文
Total: £ 56.28
Published Date: 2025-06-17 | Pages: 131 | Tables: 134 | Pharma & Healthcare
In 2024, the global market size of Travelers Vaccines was estimated to be worth US$ 3976 million and is forecast to reach approximately US$ 7118 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travelers Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and regions.
By Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by End Users
Tourists
Students
Workers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Travelers Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Travelers Vaccines sales, revenue, price, gross margin, sales by region, by Type, by End Users, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End Users, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by End Users and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Travelers Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Travelers Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Market by End Users
1.3.1 Global Travelers Vaccines Market Size Growth Rate by End Users (2020 VS 2024 VS 2031)
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Travelers Vaccines Market Size Estimates and Forecasts
2.1.1 Global Travelers Vaccines Revenue 2020-2031
2.1.2 Global Travelers Vaccines Sales 2020-2031
2.2 Travelers Vaccines Market Size by Region: 2024 Versus 2031
2.3 Travelers Vaccines Sales by Region (2020-2031)
2.3.1 Global Travelers Vaccines Sales by Region: 2020-2025
2.3.2 Global Travelers Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Travelers Vaccines Sales Market Share by Region (2020-2031)
2.4 Travelers Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Travelers Vaccines Revenue by Region: 2020-2025
2.4.2 Global Travelers Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Travelers Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Travelers Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Travelers Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Travelers Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Travelers Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Travelers Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Travelers Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Travelers Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by End Users
3.2.1 Global Travelers Vaccines Sales by End Users (2020-2031)
3.2.1.1 Global Travelers Vaccines Sales Volume by End Users (2020-2031)
3.2.1.2 Global Travelers Vaccines Sales Market Share by End Users (2020-2031)
3.2.2 Global Travelers Vaccines Revenue by End Users (2020-2031)
3.2.2.1 Global Travelers Vaccines Revenue by End Users (2020-2031)
3.2.2.2 Global Travelers Vaccines Revenue Market Share by End Users (2020-2031)
3.2.3 Travelers Vaccines Average Selling Price (ASP) by End Users (2020-2031)
3.3 by Type and by End Users Crossing Analysis
3.3.1 Meningococcal Vaccine of Travelers Vaccines Revenue Market Share by End Users
3.3.2 Japanese Encephalitis Vaccine of Travelers Vaccines Revenue Market Share by End Users
3.3.3 Yellow Fever Vaccine of Travelers Vaccines Revenue Market Share by End Users
3.3.4 Hepatitis Vaccine of Travelers Vaccines Revenue Market Share by End Users
3.3.5 Cholera Vaccine of Travelers Vaccines Revenue Market Share by End Users
3.3.6 Other of Travelers Vaccines Revenue Market Share by End Users
4 Global Travelers Vaccines by Manufacturers
4.1 Global Top Travelers Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Travelers Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Travelers Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Travelers Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Travelers Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Travelers Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Travelers Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Travelers Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Travelers Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Travelers Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Travelers Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Travelers Vaccines Market
4.5.3 Manufacturers Travelers Vaccines Product Type and Application
4.5.4 Meningococcal Vaccine Market Sales of Travelers Vaccines by Manufacturer
4.5.5 Japanese Encephalitis Vaccine Market Sales of Travelers Vaccines by Manufacturer
4.5.6 Yellow Fever Vaccine Market Sales of Travelers Vaccines by Manufacturer
4.5.7 Hepatitis Vaccine Market Sales of Travelers Vaccines by Manufacturer
4.5.8 Cholera Vaccine Market Sales of Travelers Vaccines by Manufacturer
4.5.9 Other Market Sales of Travelers Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Company Information
5.1.2 GlaxoSmithKline Description, Business Overview
5.1.3 GlaxoSmithKline Travelers Vaccines Products Offered
5.1.4 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GlaxoSmithKline Travelers Vaccines Sales by Product in 2024
5.1.6 GlaxoSmithKline Travelers Vaccines Sales by End Users in 2024
5.1.7 GlaxoSmithKline Travelers Vaccines Sales by Geographic Area in 2024
5.1.8 GlaxoSmithKline Recent Developments
5.2 Sanofi Pasteur
5.2.1 Sanofi Pasteur Company Information
5.2.2 Sanofi Pasteur Description, Business Overview
5.2.3 Sanofi Pasteur Travelers Vaccines Products Offered
5.2.4 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi Pasteur Travelers Vaccines Sales by Product in 2024
5.2.6 Sanofi Pasteur Travelers Vaccines Sales by End Users in 2024
5.2.7 Sanofi Pasteur Travelers Vaccines Sales by Geographic Area in 2024
5.2.8 Sanofi Pasteur Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Travelers Vaccines Products Offered
5.3.4 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Travelers Vaccines Sales by Product in 2024
5.3.6 Merck Travelers Vaccines Sales by End Users in 2024
5.3.7 Merck Travelers Vaccines Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Travelers Vaccines Products Offered
5.4.4 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Travelers Vaccines Sales by Product in 2024
5.4.6 Pfizer Travelers Vaccines Sales by End Users in 2024
5.4.7 Pfizer Travelers Vaccines Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 CNBG
5.5.1 CNBG Company Information
5.5.2 CNBG Description, Business Overview
5.5.3 CNBG Travelers Vaccines Products Offered
5.5.4 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CNBG Travelers Vaccines Sales by Product in 2024
5.5.6 CNBG Travelers Vaccines Sales by End Users in 2024
5.5.7 CNBG Travelers Vaccines Sales by Geographic Area in 2024
5.5.8 CNBG Recent Developments
5.6 Sanofi Pasteur MSD
5.6.1 Sanofi Pasteur MSD Company Information
5.6.2 Sanofi Pasteur MSD Description, Business Overview
5.6.3 Sanofi Pasteur MSD Travelers Vaccines Products Offered
5.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sanofi Pasteur MSD Travelers Vaccines Sales by Product in 2024
5.6.6 Sanofi Pasteur MSD Travelers Vaccines Sales by End Users in 2024
5.6.7 Sanofi Pasteur MSD Travelers Vaccines Sales by Geographic Area in 2024
5.6.8 Sanofi Pasteur MSD Recent Developments
5.7 Serum Institute of India
5.7.1 Serum Institute of India Company Information
5.7.2 Serum Institute of India Description, Business Overview
5.7.3 Serum Institute of India Travelers Vaccines Products Offered
5.7.4 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Serum Institute of India Travelers Vaccines Sales by Product in 2024
5.7.6 Serum Institute of India Travelers Vaccines Sales by End Users in 2024
5.7.7 Serum Institute of India Travelers Vaccines Sales by Geographic Area in 2024
5.7.8 Serum Institute of India Recent Developments
5.8 Biokangtai
5.8.1 Biokangtai Company Information
5.8.2 Biokangtai Description, Business Overview
5.8.3 Biokangtai Travelers Vaccines Products Offered
5.8.4 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Biokangtai Travelers Vaccines Sales by Product in 2024
5.8.6 Biokangtai Travelers Vaccines Sales by End Users in 2024
5.8.7 Biokangtai Travelers Vaccines Sales by Geographic Area in 2024
5.8.8 Biokangtai Recent Developments
6 North America
6.1 North America Travelers Vaccines Market Size YoY Growth 2020-2031
6.2 North America Travelers Vaccines Market Facts & Figures by Country
6.2.1 North America Travelers Vaccines Sales by Country (2020-2031)
6.2.2 North America Travelers Vaccines Revenue by Country (2020-2031)
6.3 North America Travelers Vaccines Sales by Type (2020-2025)
6.4 North America Travelers Vaccines Sales by End Users (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Travelers Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Travelers Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Travelers Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Travelers Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Travelers Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Travelers Vaccines Sales by End Users (2020-2025)
8 Europe
8.1 Europe Travelers Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Travelers Vaccines Market Facts & Figures by Country
8.2.1 Europe Travelers Vaccines Sales by Country (2020-2031)
8.2.2 Europe Travelers Vaccines Revenue by Country (2020-2031)
8.3 Europe Travelers Vaccines Sales by Type (2020-2025)
8.4 Europe Travelers Vaccines Sales by End Users (2020-2025)
9 Latin America
9.1 Latin America Travelers Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Travelers Vaccines Market Facts & Figures by Country
9.2.1 Latin America Travelers Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Travelers Vaccines Revenue by Country (2020-2031)
9.3 Latin America Travelers Vaccines Sales by Type (2020-2025)
9.4 Latin America Travelers Vaccines Sales by End Users (2020-2025)
10 Middle East and Africa
10.1 Latin America Travelers Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Travelers Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Travelers Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Travelers Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Travelers Vaccines Sales by End Users (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Travelers Vaccines Supply Chain Analysis
11.2 Travelers Vaccines Key Raw Materials and Upstream Suppliers
11.3 Travelers Vaccines Clients Analysis
11.4 Travelers Vaccines Sales Channel and Sales Model Analysis
11.4.1 Travelers Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Travelers Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Travelers Vaccines Distributors
12 Travelers Vaccines Market Dynamics
12.1 Travelers Vaccines Industry Trends
12.2 Travelers Vaccines Market Drivers
12.3 Travelers Vaccines Market Challenges
12.4 Travelers Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Travelers Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Travelers Vaccines Market Size Growth by End Users (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Travelers Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Travelers Vaccines Sales by Region (2020-2025) & (K Doses)
Table 5. Global Travelers Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 6. Global Travelers Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Travelers Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Travelers Vaccines Sales Volume by Type (2020-2025) & (K Doses)
Table 9. Global Travelers Vaccines Sales Volume by Type (2026-2031) & (K Doses)
Table 10. Global Travelers Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Travelers Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Travelers Vaccines Sales Volume by End Users (2020-2025) & (K Doses)
Table 13. Global Travelers Vaccines Sales Volume by End Users (2026-2031) & (K Doses)
Table 14. Global Travelers Vaccines Revenue by End Users (2020-2025) & (US$ Million)
Table 15. Global Travelers Vaccines Revenue by End Users (2026-2031) & (US$ Million)
Table 16. Global Travelers Vaccines Sales by Manufacturer (2020-2025) & (K Doses)
Table 17. Global Travelers Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Travelers Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Travelers Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Travelers Vaccines Price (2020-2025) & (USD/Dose)
Table 21. Ranking of Global Top Travelers Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Travelers Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2024)
Table 24. Travelers Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Travelers Vaccines Market
Table 26. Manufacturers Travelers Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GlaxoSmithKline Company Information
Table 29. GlaxoSmithKline Description and Business Overview
Table 30. GlaxoSmithKline Travelers Vaccines Product
Table 31. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 32. GlaxoSmithKline Sales Proportion of Travelers Vaccines by Product in 2024
Table 33. GlaxoSmithKline Sales Proportion of Travelers Vaccines by End Users in 2024
Table 34. GlaxoSmithKline Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 35. GlaxoSmithKline Recent Developments
Table 36. Sanofi Pasteur Company Information
Table 37. Sanofi Pasteur Description and Business Overview
Table 38. Sanofi Pasteur Travelers Vaccines Product
Table 39. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 40. Sanofi Pasteur Sales Proportion of Travelers Vaccines by Product in 2024
Table 41. Sanofi Pasteur Sales Proportion of Travelers Vaccines by End Users in 2024
Table 42. Sanofi Pasteur Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 43. Sanofi Pasteur Recent Developments
Table 44. Merck Company Information
Table 45. Merck Description and Business Overview
Table 46. Merck Travelers Vaccines Product
Table 47. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 48. Merck Sales Proportion of Travelers Vaccines by Product in 2024
Table 49. Merck Sales Proportion of Travelers Vaccines by End Users in 2024
Table 50. Merck Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 51. Merck Recent Developments
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Travelers Vaccines Product
Table 55. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 56. Pfizer Sales Proportion of Travelers Vaccines by Product in 2024
Table 57. Pfizer Sales Proportion of Travelers Vaccines by End Users in 2024
Table 58. Pfizer Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 59. Pfizer Recent Developments
Table 60. CNBG Company Information
Table 61. CNBG Description and Business Overview
Table 62. CNBG Travelers Vaccines Product
Table 63. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 64. CNBG Sales Proportion of Travelers Vaccines by Product in 2024
Table 65. CNBG Sales Proportion of Travelers Vaccines by End Users in 2024
Table 66. CNBG Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 67. CNBG Recent Developments
Table 68. Sanofi Pasteur MSD Company Information
Table 69. Sanofi Pasteur MSD Description and Business Overview
Table 70. Sanofi Pasteur MSD Travelers Vaccines Product
Table 71. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 72. Sanofi Pasteur MSD Sales Proportion of Travelers Vaccines by Product in 2024
Table 73. Sanofi Pasteur MSD Sales Proportion of Travelers Vaccines by End Users in 2024
Table 74. Sanofi Pasteur MSD Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 75. Sanofi Pasteur MSD Recent Developments
Table 76. Serum Institute of India Company Information
Table 77. Serum Institute of India Description and Business Overview
Table 78. Serum Institute of India Travelers Vaccines Product
Table 79. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Serum Institute of India Sales Proportion of Travelers Vaccines by Product in 2024
Table 81. Serum Institute of India Sales Proportion of Travelers Vaccines by End Users in 2024
Table 82. Serum Institute of India Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 83. Serum Institute of India Recent Developments
Table 84. Biokangtai Company Information
Table 85. Biokangtai Description and Business Overview
Table 86. Biokangtai Travelers Vaccines Product
Table 87. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Biokangtai Sales Proportion of Travelers Vaccines by Product in 2024
Table 89. Biokangtai Sales Proportion of Travelers Vaccines by End Users in 2024
Table 90. Biokangtai Sales Proportion of Travelers Vaccines by Geographic Area in 2024
Table 91. Biokangtai Recent Developments
Table 92. North America Travelers Vaccines Sales by Country (2020-2025) & (K Doses)
Table 93. North America Travelers Vaccines Sales by Country (2026-2031) & (K Doses)
Table 94. North America Travelers Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Travelers Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 97. North America Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 98. Asia-Pacific Travelers Vaccines Sales by Region (2020-2025) & (K Doses)
Table 99. Asia-Pacific Travelers Vaccines Sales by Region (2026-2031) & (K Doses)
Table 100. Asia-Pacific Travelers Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Travelers Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 103. Asia-Pacific Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 104. Europe Travelers Vaccines Sales by Country (2020-2025) & (K Doses)
Table 105. Europe Travelers Vaccines Sales by Country (2026-2031) & (K Doses)
Table 106. Europe Travelers Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Travelers Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 109. Europe Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 110. Latin America Travelers Vaccines Sales by Country (2020-2025) & (K Doses)
Table 111. Latin America Travelers Vaccines Sales by Country (2026-2031) & (K Doses)
Table 112. Latin America Travelers Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Travelers Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 115. Latin America Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 116. Middle East and Africa Travelers Vaccines Sales by Country (2020-2025) & (K Doses)
Table 117. Middle East and Africa Travelers Vaccines Sales by Country (2026-2031) & (K Doses)
Table 118. Middle East and Africa Travelers Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Travelers Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 121. Middle East and Africa Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 122. Travelers Vaccines Key Raw Materials, Industry Status and Trend
Table 123. Travelers Vaccines Key Raw Materials and Upstream Suppliers
Table 124. Travelers Vaccines Clients Status and Trend
Table 125. Travelers Vaccines Typical Clients
Table 126. Travelers Vaccines Distributors
Table 127. Travelers Vaccines Market Trends
Table 128. Travelers Vaccines Market Drivers
Table 129. Travelers Vaccines Market Challenges
Table 130. Travelers Vaccines Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Travelers Vaccines Product Picture
Figure 2. Global Travelers Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Travelers Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Japanese Encephalitis Vaccine Product Picture
Figure 6. Yellow Fever Vaccine Product Picture
Figure 7. Hepatitis Vaccine Product Picture
Figure 8. Cholera Vaccine Product Picture
Figure 9. Other Product Picture
Figure 10. Global Travelers Vaccines Market Size by End Users (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Travelers Vaccines Sales Market Share by End Users in 2024 & 2031
Figure 12. Tourists
Figure 13. Students
Figure 14. Workers
Figure 15. Others
Figure 16. Travelers Vaccines Report Years Considered
Figure 17. Global Travelers Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Travelers Vaccines Market Size 2020-2031 (US$ Million)
Figure 19. Global Travelers Vaccines Sales 2020-2031 (K Doses)
Figure 20. Global Travelers Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 21. Global Travelers Vaccines Revenue Market Share by Region (2020-2031)
Figure 22. Global Travelers Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 23. Global Travelers Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 24. Travelers Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
Figure 25. Global Travelers Vaccines Sales Market Share Forecast by End Users (2020-2031)
Figure 26. Global Travelers Vaccines Revenue Market Share Forecast by End Users (2020-2031)
Figure 27. Travelers Vaccines Average Selling Price (ASP) by End Users (2020-2025) & (USD/Dose)
Figure 28. Meningococcal Vaccine of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 29. Japanese Encephalitis Vaccine of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 30. Yellow Fever Vaccine of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 31. Hepatitis Vaccine of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 32. Cholera Vaccine of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 33. Other of Travelers Vaccines Revenue Market Share by End Users, 2024 VS 2031
Figure 34. Global Travelers Vaccines Sales Share by Manufacturer in 2024
Figure 35. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Meningococcal Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 37. Japanese Encephalitis Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 38. Yellow Fever Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 39. Hepatitis Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 40. Cholera Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 41. Other Market Sales Proportion by Manufacturer in 2024
Figure 42. North America Travelers Vaccines Revenue 2020-2031 (US$ Million)
Figure 43. North America Travelers Vaccines Sales Market Share by Type (2020-2025)
Figure 44. North America Travelers Vaccines Sales Market Share by End Users (2020-2025)
Figure 45. Asia-Pacific Travelers Vaccines Revenue 2020-2031 (US$ Million)
Figure 46. Asia-Pacific Travelers Vaccines Sales Market Share by Region (2020-2031)
Figure 47. Asia-Pacific Travelers Vaccines Revenue Market Share by Region (2020-2031)
Figure 48. Asia-Pacific Travelers Vaccines Sales Market Share by Type (2020-2025)
Figure 49. Asia-Pacific Travelers Vaccines Sales Market Share by End Users (2020-2025)
Figure 50. Europe Travelers Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Europe Travelers Vaccines Sales Market Share by Country (2020-2031)
Figure 52. Europe Travelers Vaccines Revenue Market Share by Country (2020-2031)
Figure 53. Europe Travelers Vaccines Sales Market Share by Type (2020-2025)
Figure 54. Europe Travelers Vaccines Sales Market Share by End Users (2020-2025)
Figure 55. Latin America Travelers Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Latin America Travelers Vaccines Sales Market Share by Country (2020-2031)
Figure 57. Latin America Travelers Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Latin America Travelers Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Latin America Travelers Vaccines Sales Market Share by End Users (2020-2025)
Figure 60. Middle East and Africa Travelers Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 61. Middle East and Africa Travelers Vaccines Sales Market Share by Country (2020-2031)
Figure 62. Middle East and Africa Travelers Vaccines Revenue Market Share by Country (2020-2031)
Figure 63. Middle East and Africa Travelers Vaccines Sales Market Share by Type (2020-2025)
Figure 64. Middle East and Africa Travelers Vaccines Sales Market Share by End Users (2020-2025)
Figure 65. Travelers Vaccines Supply Chain (Upstream and Downstream Market)
Figure 66. Global Production Market Share of Travelers Vaccines Raw Materials by Region in 2024
Figure 67. Travelers Vaccines Distribution Channels
Figure 68. Global Travelers Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 69. Global Travelers Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
